Alcohol-Induced Disorders, Nervous System: Clinical Trials

16 trials for Alcohol-Induced Disorders, Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 terminated, 2 unknown, 2 withdrawn. 6 Not applicable, 3 Phase 4, 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 43Completed 1, Terminated 1, Unknown 1
Phase 22Withdrawn 2
Phase 11Completed 1
Phase 31Completed 1

Follow Alcohol-Induced Disorders, Nervous System: new trials by email Literature Review of Alcohol-Induced Disorders, Nervous System trials Research Report on Alcohol-Induced Disorders, Nervous System

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care
Preventox, a digital self-help tool for patients with intoxications in intensive care., Preventox control group - Intoxication, Delirium Tremens (DTs)
Not applicableNot yet recruitingKarolinska Institutet502026-09-302026-09-23
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
Phenobarbital Sodium, Inactive placebo - Alcohol Withdrawal Delirium, Alcohol Withdrawal
Not applicableTerminatedUnity Health Toronto82021-06-112023-11-02
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
Phenobarbital, Lorazepam - Alcohol Withdrawal, Alcohol Withdrawal Delirium
Phase 4UnknownOSF Healthcare System1422020-07-062020-10-08
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
Dexmedetomidine 0.004 MG/ML, Diazepam Injectable Solution - Alcohol Withdrawal Delirium
Phase 4CompletedCentro Medico Nacional La Raza, IMSS22017-11-012019-03-15
A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment
Pitolisant (BF2.649), Placebo - Alcohol Abuse, Nervous System
Phase 2WithdrawnBioprojet2016-10-012017-01-12
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
BACLOFEN, PLACEBO - Alcoholism
Phase 3CompletedNantes University Hospital3142016-06-272026-09-14
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
oxytocin, placebo - Alcoholism, Alcohol Related Disorders
Phase 1CompletedJohns Hopkins University272015-03-012017-12-04
Hyperbaric Oxygenation in Treatment of Alcohol Dependence Syndrome
Hyperbaric Oxygenation Therapy, Normobaric Oxygenation therapy - Alcohol Withdrawal Symptoms, Delirium Tremens (DTs)
Not applicableCompletedJubilee Mission Medical College and Research Institute302014-11-012018-03-19
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
BZDP-Sparing Protocol, BZDP-Based Protocol - Alcohol Withdrawal Syndrome
CompletedStanford University302013-08-012022-06-30
Health Mobile Cognitive Stimulation in Alcohol Use Disorder
Mobile health cognitive stimulation - Alcohol-Induced Disorders, Nervous System, Alcohol Dependence
Not applicableCompletedPedro Gamito542012-10-012023-05-11
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)
Alcohol Withdrawal Syndrome
CompletedStanford University4092012-05-012015-01-30
Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)
Dexmedetomidine, Placebos - Alcohol Withdrawal Delirium, Alcohol Withdrawal Associated Autonomic Hyperactivity
Phase 4TerminatedDenver Health and Hospital Authority492012-03-012017-11-06
From Uncomplicated Alcoholism to Korsakoff's Syndrome
Neuropsychological testing, blood draw, genetic testing - Alcoholism, Alcohol Amnestic Disorder
Not applicableUnknownUniversity Hospital, Caen2202012-01-012014-04-09
Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic
Psychiatric and somatic examinations and ,if clinical indicated, treatment - HEART DISEASE, Liver Failure
CompletedHelse Nord-Trøndelag HF1502010-03-012021-11-09
Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study
levetiracetam - Seizure, Alcohol Related
Phase 2WithdrawnMedical University of South Carolina2008-02-012018-06-07
Treating Alcohol Withdrawal With Oral Baclofen
Baclofen, Placebo, Lorazepam - Alcohol Withdrawal Delirium
Not applicableCompletedEssentia Health792003-04-012011-07-27

Narrower conditions

Alcohol Withdrawal Delirium (11)  ·  Alcoholism (6)  ·  Alcohol Withdrawal Seizures (4)  ·  Alcohol Amnestic Disorder (1)  ·  Alcohol-Related Disorders (1)  ·  Alcoholic Neuropathy (1)  ·  Behavior (1)  ·  Depression (1)  ·  Depressive Disorder (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Liver Failure (1)  ·  Psychomotor Agitation (1)  ·  Tremor (1)

Broader conditions

Alcohol-Induced Disorders (16)  ·  Chemically-Induced Disorders (16)  ·  Nervous System Diseases (16)  ·  Neurotoxicity Syndromes (16)  ·  Poisoning (16)  ·  Substance-Related Disorders (16)  ·  Alcohol-Related Disorders (15)  ·  Mental Disorders (14)  ·  Substance Withdrawal Syndrome (12)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Seizures (4)  ·  Behavior (2)

Interventions

Baclofen (2)  ·  Dexmedetomidine (2)  ·  Lorazepam (2)  ·  Phenobarbital (2)  ·  Benzyl Alcohols (1)  ·  Blood Specimen Collection (1)  ·  Critical Care (1)  ·  Diazepam (1)  ·  Genetic Testing (1)  ·  Hyperbaric Oxygenation (1)  ·  Levetiracetam (1)  ·  Neuropsychological Tests (1)  ·  Oxytocin (1)  ·  Psychiatry (1)  ·  Therapeutics (1)

Sponsors

Stanford University (2)  ·  Bioprojet (1)  ·  Centro Medico Nacional La Raza, IMSS (1)  ·  Denver Health and Hospital Authority (1)  ·  Essentia Health (1)  ·  Helse Nord-Trøndelag HF (1)  ·  Johns Hopkins University (1)  ·  Jubilee Mission Medical College and Research Institute (1)  ·  Karolinska Institutet (1)  ·  Medical University of South Carolina (1)  ·  Nantes University Hospital (1)  ·  OSF Healthcare System (1)  ·  Pedro Gamito (1)  ·  Unity Health Toronto (1)  ·  University Hospital, Caen (1)

Countries

United States (7)  ·  France (2)  ·  Canada (1)  ·  Mexico (1)  ·  Norway (1)  ·  Portugal (1)

Top investigators

Bhagat Aulakh, MD (1)  ·  Elise Weerts, Ph.D. (1)  ·  Erling Dalen, MD (1)  ·  Ivor S Douglas, MD, FRCP (1)  ·  Jeffrey Lyon, MD (1)  ·  Jorge AG Oliveira, PhD (1)  ·  Jose Maldonado, MD (1)  ·  Jose R Maldonado, MD (1)  ·  Karen Burns (1)  ·  Paulo JF Lopes, PhD (1)  ·  Pedro SP Gamito, PhD (1)

Results publications

PMID 20944765, PMID 20951277, PMID 22898443, PMID 24657098, PMID 24742381, PMID 25625990, PMID 27542731, PMID 33423824, PMID 33620407, PMID 35065662, PMID 8701843

NIH funding

2025 (1)